A number of other equities analysts have also recently commented on PAHC. Barclays reiterated a “hold” rating on shares of Bank of Montreal in a report on Tuesday, June 11th. ValuEngine downgraded shares of Verso from a “hold” rating to a “sell” rating in a research report on Thursday, May 23rd. Guggenheim reiterated a “buy” rating and issued a $95.00 price target (up from $90.00) on shares of VF in a research report on Thursday, May 23rd. Zacks Investment Research upgraded shares of Triple-S Management from a “hold” rating to a “buy” rating and set a $26.00 price target for the company in a research report on Monday, April 29th. Finally, Gabelli upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 price target for the company in a research report on Wednesday, May 8th. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $41.50.
PAHC stock traded up $0.42 during trading hours on Wednesday, reaching $30.39. 62,746 shares of the stock were exchanged, compared to its average volume of 164,903. The firm’s 50-day simple moving average is $30.41. The company has a market cap of $1.23 billion, a P/E ratio of 17.36, a price-to-earnings-growth ratio of 4.26 and a beta of 0.74. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.98 and a current ratio of 3.41. Phibro Animal Health has a 12 month low of $27.32 and a 12 month high of $54.62.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Advisors Asset Management Inc. lifted its position in Phibro Animal Health by 52.3% during the fourth quarter. Advisors Asset Management Inc. now owns 2,536 shares of the company’s stock worth $82,000 after acquiring an additional 871 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of Phibro Animal Health by 19.9% in the 4th quarter. Rhumbline Advisers now owns 58,359 shares of the company’s stock worth $1,877,000 after acquiring an additional 9,699 shares during the last quarter. Victory Capital Management Inc. grew its position in Phibro Animal Health by 4.1% in the 4th quarter. Victory Capital Management Inc. now owns 10,756 shares of the company’s stock worth $346,000 after purchasing an additional 419 shares in the last quarter. Oregon Public Employees Retirement Fund bought a new position in shares of Phibro Animal Health during the 4th quarter valued at approximately $247,000. Finally, California Public Employees Retirement System grew its position in shares of Phibro Animal Health by 34.5% during the 4th quarter. California Public Employees Retirement System now owns 46,524 shares of the company’s stock valued at $1,496,000 after acquiring an additional 11,939 shares during the period. Hedge funds and other institutional investors own 50.28% of the company’s stock.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Read More: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.